Digital Health Inside Out

Oura is heading to the public markets (or not?). ChatGPT is connecting directly with Epic. And one of the largest health systems in the U.S. is paying $1.9 billion to walk away from an outsourced revenue cycle management contract.In this episode of Digital Health Vitals, we break down some of the biggest digital health and healthtech stories from September 2026 — from the Oura IPO and the future of wearables to ChatGPT for Healthcare + Epic, the changing competitive landscape for healthcare AI, and whether RCM insourcing could become a bigger trend across healthcare.Joining Alex Koshykov and Sergei Polevikov this month is special guest Patrick Donohue, founder of Hill Capital Corporation and a longtime healthcare investor with experience across investment banking, medical devices, private markets, and founder-led businesses.We also bring back our Thumbs Up / Thumbs Down funding game to discuss four major healthtech rounds: Heidi Health, Tandem Health, Archy, and Rightway.

Healthcare earnings, Epic's biggest conference of the year, Oracle Health's strategy, public healthtech stocks, and one of the industry's most talked-about investigations.In this episode of Digital Health Vitals, Alex Koshykov, Sergei Polevikov, Stephanie Davis, and special guest Bailey Morgan break down the biggest developments shaping digital health.We discuss the winners and losers of Q2 earnings, why Doximity surprised Wall Street, whether Amwell is finally turning the corner, what Epic actually announced at UGM, Oracle Health's future after Cerner, and the ongoing debate around the Stat investigation into Commure. We also cover R1's latest acquisitions and what they mean for the future of revenue cycle management and prior authorization.Whether you're a founder, investor, provider, or simply interested in healthcare innovation, this episode offers practical insights into where digital health is heading.Host/Moderator:Alex Koshykov — CEO @ YODD, COO @ BeKey.io https://www.linkedin.com/in/alex-koshykov/Experts:Sergei Polevikov ‪@sergeiAI‬ — Founder of AI Health Uncut https://www.linkedin.com/in/sergeiai/AI Health Uncut: https://FixHealth.aiStephanie Davis — Healthcare Industry Analyst https://www.linkedin.com/in/stephjdavis/Bailey Morgan - Chief of Staff @ Groth Pain & Spinehttps://www.linkedin.com/in/bailey-morgan7/Topics covered:- Q2 healthtech earnings: winners, losers, and what Wall Street is signaling- Why Teladoc continues to struggle while Talkspace gains momentum- Doximity's strong quarter and whether OpenEvidence is a real competitive threat- Can Amwell finally complete its turnaround?- Epic UGM 2026: biggest AI announcements and product launches- Epic vs Oracle Health: who will shape the future of the EHR market?- Ambient AI, clinical decision support, and the battle between Epic, Abridge, Microsoft, and Nuance- Is Epic becoming too dominant in healthcare?- Oracle Health, Cerner, and the future of the VA modernization project- The Commure investigation: partnerships, referral fees, and healthcare business ethics- R1's AI strategy and the future of revenue cycle management- Prior authorization automation, CMS rules, and where healthcare operations are heading

Heidi CEO and co-founder Thomas Kelly and Chief Medical Officer Simon Kos discuss the future of AI medical scribes, clinical documentation, and generative AI in healthcare.In this episode of Digital Health Inside Out, we explore how Heidi is evolving beyond AI-powered medical transcription to become a broader clinical AI platform. Thomas and Simon explain Heidi’s mission to double the world’s healthcare capacity, whether AI scribes genuinely save clinicians time, and how healthcare organizations can use AI without compromising safety.We also discuss medical AI hallucinations, billing and upcoding, EHR integration, FDA regulation, product-led growth, and competition with Epic, Microsoft, and frontier AI model providers. Thomas shares why Heidi began building specialized AI models, while Simon explains what comes after AI scribes and how Heidi plans to expand within US health systems.

Is healthcare AI entering its next phase?

In this episode of Digital Health Vitals, we break down the biggest digital health stories from July 2026, including the new Stanford & Harvard ARISE Healthcare AI Report, Health in ChatGPT, the FDA's TEMPO pilot with Dexcom, new payment models for clinical AI, and several major fundraising rounds across the industry.

In this episode of Digital Health Inside Out, we sit down with Amit Phull, MD, Chief Clinical Experience Officer at Doximity, to discuss the next era of clinical AI, physician workflows, and what it really takes to build technology that doctors can trust.Amit shares his journey from emergency medicine and computer science to joining Doximity in its early days, how the company evolved from “LinkedIn for doctors” into a clinical workflow platform, and why user feedback from physicians remains central to Doximity’s product strategy.We discuss Doximity’s Clinical AI Suite, Doximity Ask, the acquisition of Pathway, the role of knowledge graphs and retrieval in clinical AI, and the company’s Peer Check initiative, where thousands of physicians review AI-generated clinical answers. Amit also explains why trust, accuracy, and reliability are still the biggest barriers to AI adoption in healthcare.The conversation also covers telemedicine, ambient documentation, physician burnout, pharma advertising, enterprise healthcare partnerships, competition in clinical AI, and the ongoing debate around general-purpose AI models versus specialized healthcare AI tools.If you are building, investing in, or adopting healthcare AI, this interview offers a rare inside look at how one of the largest physician networks in the U.S. is approaching AI in medicine.Topics covered:

• Doximity’s evolution and “eras”
• Clinical AI Suite and Doximity Ask
• Peer Check and physician-reviewed AI answers
• Pathway’s clinical knowledge graph
• AI trust, accuracy, and reliability in healthcare
• Physician burnout and administrative burden
• Telemedicine and clinical workflow tools
• Competition in clinical AI
• The future of AI in healthcare

Guest:Amit Phull — Chief Clinical Experience Officer at Doximityhttps://www.linkedin.com/in/amit-phull-09931667/Co-Host:Alex Koshykov — CEO @ YODD, COO @ BeKey.io https://www.linkedin.com/in/alex-koshykov/Co-Host:Sergei Polevikov @sergeiAI — Founder of AI Health Uncuthttps://www.linkedin.com/in/sergeiai/

In this episode of Digital Health Vitals, we break down the biggest digital health and healthcare AI stories from June — including a new Nature Medicine paper on general-purpose LLMs outperforming specialized clinical AI tools, OpenEvidence’s controversial response, UnitedHealth’s $3B AI investment, Midjourney Medical’s ultrasonic body scanner concept, and Abridge’s new AI-native clinician intelligence platform.This episode features Alex Koshykov, Sergei Polevikov, Stephanie Davis, and special guest Amit Phull — emergency medicine physician, clinical assistant professor at GW, and Chief Clinical Experience Officer at Doximity.

In this live episode of Digital Health Vitals, recorded during our Health2Tech Tech Week event in New York, we bring our monthly digital health news discussion to the stage. We break down what is happening across healthcare AI, digital health startups, health tech investing, public markets, direct-to-consumer healthcare, AI health companions, care navigation, and administrative automation.

In this episode of Digital Health Inside Out, Alex Koshykov and Sergei Polevikov sit down with Piotr Orzechowski, founder and CEO of Infermedica, one of the most established companies in AI-powered symptom assessment and clinical triage.We discuss how the symptom-checker category has changed, why standalone consumer symptom checkers may be “dead,” and why clinical-grade AI triage is still becoming more important within real healthcare workflows.Piotr shares the story of building Infermedica from Poland into a global healthtech company, the challenges of selling medical AI internationally, how Infermedica competes in the age of ChatGPT and LLMs, and why medical device certification, physician validation, liability, and evidence still matter.We also cover AI accuracy claims, peer-reviewed validation, neurosymbolic AI, voice-based triage, fundraising for founders from Eastern Europe, the future of AI diagnosis, and what kind of companies might eventually acquire Infermedica.If you care about healthcare AI, digital health, symptom checkers, clinical triage, LLMs in medicine, or the future of regulated medical AI, this conversation is for you.

GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have become one of the biggest stories in healthcare, obesity medicine, pharma, telehealth, and even culture.But are GLP-1s truly transforming obesity care — or are we outsourcing willpower to pharma?In this episode of Digital Health Inside Out, Alex Koshykov and Sergey Polevikov sit down with Dr. Beverly Chang, Dave Knapp, and Sean Sullivan to unpack the science, business, safety concerns, access issues, and social debate around GLP-1 medications.

In this episode of Digital Health Vitals, we break down the biggest stories shaping digital health, healthcare AI, health tech investing, payer strategy, value-based care, and digital health startup funding in 2026. If you’re interested in AI in healthcare, digital health funding, healthcare startups, value-based care, payer-provider dynamics, clinical AI, healthcare public markets, or health tech business models, this episode is for you.